Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1

Status

Completed 12Recruiting 6Unknown 3Terminated 3Active not recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 25Thoracic 9Head & Neck 7CNS 7Breast 7Sarcoma 6Genitourinary 5Gynecologic 4Dermatologic 3Endocrine 2Other 1

Conditions

Melanoma 2Skin Neoplasms 1Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 58Cyclophosphamide 53Ipilimumab 52Nivolumab 44aldesleukin 35Interleukin-2 26fludarabine phosphate 22fludarabine 21Vemurafenib 20Temozolomide 19Radiotherapy 18dabrafenib 15trametinib 12Radiosurgery 11CTLA-4 Antigen 11Filgrastim 10Dacarbazine 10spartalizumab 9cobimetinib 9binimetinib 9atezolizumab 9Biopsy 9poly ICLC 8Paclitaxel 8Antilymphocyte Serum 8encorafenib 7avelumab 7Rituximab 7Introns 7romidepsin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Surgical Procedures, Operative × Dermatologic × Clear all
NCT06295809 2026-05-08

INTerpath-007

Merck Sharp & Dohme LLC

Phase 2/3 Terminated
46 enrolled
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms

NCT00707161 2017-03-31

Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma

University of Utah

Phase 2 Terminated
6 enrolled 4 charts
Dermatologic

Melanoma, Neoplasms

NCT01013623 2012-09-26

STG4SURG

Saint John's Cancer Institute

Phase 3 Terminated
12 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡